3-(二乙氨基)丙腈
|
P694659-1g
|
≥98% |
5351-04-2 |
1g
|
¥ 1924.9
|
期货,请咨询 |
阿拉丁 |
N-丙基酞酰亚胺
|
P694657-5g
|
≥98% |
5323-50-2 |
5g
|
¥ 6094.9
|
期货,请咨询 |
阿拉丁 |
N-丙基酞酰亚胺
|
P694657-250mg
|
≥98% |
5323-50-2 |
250mg
|
¥ 590.9
|
期货,请咨询 |
阿拉丁 |
N-丙基酞酰亚胺
|
P694657-1g
|
≥98% |
5323-50-2 |
1g
|
¥ 1604.9
|
期货,请咨询 |
阿拉丁 |
1-(4-甲氧基苯基)-3-二甲氨基-1-丙酮盐酸盐
|
P694643-5g
|
≥97% |
2125-49-7 |
5g
|
¥ 1712.9
|
期货,请咨询 |
阿拉丁 |
1-(4-甲氧基苯基)-3-二甲氨基-1-丙酮盐酸盐
|
P694643-1g
|
≥97% |
2125-49-7 |
1g
|
¥ 656.9
|
期货,请咨询 |
阿拉丁 |
2-苯基喹喔啉
|
P694638-25mg
|
≥95% |
5021-43-2 |
25mg
|
¥ 4910.9
|
期货,请咨询 |
阿拉丁 |
3-丙基吡啶
|
P694625-250mg
|
≥97% |
4673-31-8 |
250mg
|
¥ 358.9
|
期货,请咨询 |
阿拉丁 |
3-丙基吡啶
|
P694625-100mg
|
≥97% |
4673-31-8 |
100mg
|
¥ 211.9
|
期货,请咨询 |
阿拉丁 |
3-(1H-吲哚-3-基)丙腈
|
P694614-100mg
|
≥98% |
4414-76-0 |
100mg
|
¥ 2544.9
|
期货,请咨询 |
阿拉丁 |
3-苯基环戊基-2-烯酮
|
P694588-5g
|
≥97% |
3810-26-2 |
5g
|
¥ 12261.9
|
期货,请咨询 |
阿拉丁 |
3-苯基环戊基-2-烯酮
|
P694588-250mg
|
≥97% |
3810-26-2 |
250mg
|
¥ 1058.9
|
期货,请咨询 |
阿拉丁 |
3-苯基环戊基-2-烯酮
|
P694588-1g
|
≥97% |
3810-26-2 |
1g
|
¥ 3003.9
|
期货,请咨询 |
阿拉丁 |
3-苯基环戊基-2-烯酮
|
P694588-100mg
|
≥97% |
3810-26-2 |
100mg
|
¥ 624.9
|
期货,请咨询 |
阿拉丁 |
1-(3-氟苯基)哌嗪
|
P694587-1g
|
≥95% |
3801-89-6 |
1g
|
¥ 1557.9
|
期货,请咨询 |
阿拉丁 |
3-(4-氟苯基)戊二酸
|
P694566-5g
|
≥95% |
3449-63-6 |
5g
|
¥ 3610.9
|
期货,请咨询 |
阿拉丁 |
3-(4-氟苯基)戊二酸
|
P694566-250mg
|
≥95% |
3449-63-6 |
250mg
|
¥ 312.9
|
期货,请咨询 |
阿拉丁 |
3-(4-氟苯基)戊二酸
|
P694566-1g
|
≥95% |
3449-63-6 |
1g
|
¥ 884.9
|
期货,请咨询 |
阿拉丁 |
3-(4-氟苯基)戊二酸
|
P694566-100mg
|
≥95% |
3449-63-6 |
100mg
|
¥ 184.9
|
期货,请咨询 |
阿拉丁 |
(1-苯基乙烯基)磷酸
|
P694555-1g
|
≥95%, TBC作为稳定剂 |
3220-50-6 |
1g
|
¥ 6441.9
|
期货,请咨询 |
阿拉丁 |
2-(1-哌啶基)苯并噻唑
|
P694532-500mg
|
≥97% |
2851-08-3 |
500mg
|
¥ 2564.9
|
期货,请咨询 |
阿拉丁 |
3-(二丁基氨基)-1-丙醇
|
P694477-5g
|
≥97% |
2050-51-3 |
5g
|
¥ 1046.9
|
期货,请咨询 |
阿拉丁 |
3-(二丁基氨基)-1-丙醇
|
P694477-25g
|
≥97% |
2050-51-3 |
25g
|
¥ 2797.9
|
期货,请咨询 |
阿拉丁 |
3-(二丁基氨基)-1-丙醇
|
P694477-250mg
|
≥97% |
2050-51-3 |
250mg
|
¥ 139.9
|
期货,请咨询 |
阿拉丁 |